Product Information
Name:VU0071063
Controlled Product
Brand:Biosynth
Description:VU0071063 is a small molecule that inhibits the mitochondrial membrane potential, which prevents hyperinsulinism. It has been shown to have a pharmacokinetic property that makes it suitable for oral administration. VU0071063 is metabolized in the liver, but penetrates the blood-brain barrier and reaches high concentrations in the pancreas. The compound has a low toxicity profile and shows no appreciable cardiotoxicity. VU0071063 inhibits both subunits of ATP synthase, preventing movement of potassium ions across the mitochondrial membrane and increasing intracellular calcium ion levels. This leads to impaired insulin secretion by pancreatic β-cells, as well as decreased ATP production by other cells.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:326.39 g/mol
Formula:C18H22N4O2
Purity:Min. 95%
Technical inquiry about: VU0071063
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.